Gianmarco Motta

637 total citations · 1 hit paper
18 papers, 395 citations indexed

About

Gianmarco Motta is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Gianmarco Motta has authored 18 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Gianmarco Motta's work include Advanced Breast Cancer Therapies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Gianmarco Motta is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Gianmarco Motta collaborates with scholars based in Italy, Netherlands and Switzerland. Gianmarco Motta's co-authors include Paolo Vigneri, Federica Martorana, Livia Manzella, Stefania Stella, Silvia Rita Vitale, Giuliana Pavone, Lucia Motta, Michele Massimino, Elena Tirrò and Chiara Romano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Gianmarco Motta

16 papers receiving 392 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?

2021 160 citations Federica Martorana, Gianmarco Motta et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gianmarco Motta Italy	9	194	127	85	80	71	18	395
Giorgia Federico Italy	10	220 1.1×	111 0.9×	186 2.2×	124 1.6×	57 0.8×	22	518
Isabel Conde Spain	13	149 0.8×	105 0.8×	72 0.8×	85 1.1×	62 0.9×	17	408
Qing-Yun Chong Singapore	14	280 1.4×	140 1.1×	109 1.3×	184 2.3×	51 0.7×	16	472
Jason L. Rowand United States	5	251 1.3×	125 1.0×	80 0.9×	62 0.8×	50 0.7×	6	369
Elena G. Chiorean United States	8	323 1.7×	143 1.1×	53 0.6×	262 3.3×	67 0.9×	18	643
Stephen Hillerman United States	4	241 1.2×	118 0.9×	80 0.9×	105 1.3×	132 1.9×	5	427
Kelly E. Fisher United States	4	434 2.2×	288 2.3×	76 0.9×	80 1.0×	41 0.6×	6	599
Maya Ridinger United States	9	155 0.8×	118 0.9×	51 0.6×	46 0.6×	36 0.5×	41	302
Ivana Galetić Switzerland	7	315 1.6×	64 0.5×	107 1.3×	48 0.6×	21 0.3×	10	494
Victoria Rimkunas United States	10	276 1.4×	272 2.1×	225 2.6×	108 1.4×	24 0.3×	26	556

Countries citing papers authored by Gianmarco Motta

Since Specialization

Citations

This map shows the geographic impact of Gianmarco Motta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianmarco Motta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianmarco Motta more than expected).

Fields of papers citing papers by Gianmarco Motta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianmarco Motta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianmarco Motta. The network helps show where Gianmarco Motta may publish in the future.

Co-authorship network of co-authors of Gianmarco Motta

This figure shows the co-authorship network connecting the top 25 collaborators of Gianmarco Motta. A scholar is included among the top collaborators of Gianmarco Motta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianmarco Motta. Gianmarco Motta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Valerio, Maria Rosaria, Federica Martorana, Daniela Sambataro, et al.. (2025). Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer. Biomedicines. 13(3). 546–546. 2 indexed citations

Motta, Gianmarco, et al.. (2025). One Health: Action in Brazilian Cases of Sporotrichosis in Humans and Cats. Pathogens. 14(3). 225–225. 1 indexed citations

Motta, Lucia, Maria Ausiliatrice Puglisi, Giuliana Pavone, et al.. (2025). Unveiling Prostate-Specific Membrane Antigen’s Potential in Breast Cancer Management. Cancers. 17(3). 456–456. 1 indexed citations

Helmijr, Jean, Gianmarco Motta, Vanja de Weerd, et al.. (2024). A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis. The Journal of Applied Laboratory Medicine. 9(5). 913–925. 1 indexed citations

Conti, Chiara, Gianmarco Motta, Federica Martorana, et al.. (2024). REThinking the role of the RET oncogene in breast cancer. Frontiers in Oncology. 14. 1427228–1427228.

Lanza, Marika, Alessia Filippone, Giovanna Casili, et al.. (2023). Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition. International Journal of Molecular Sciences. 24(3). 2777–2777. 8 indexed citations

Tirrò, Elena, Michele Massimino, Giuseppe Broggi, et al.. (2022). A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications. Frontiers in Oncology. 12. 861078–861078. 23 indexed citations

Tirrò, Elena, Federica Martorana, Nicola Inzerilli, et al.. (2022). Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience. Pathology - Research and Practice. 232. 153820–153820. 6 indexed citations

Stella, Stefania, Silvia Rita Vitale, Michele Massimino, et al.. (2022). Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer. Cancer Genomics & Proteomics. 19(4). 464–476. 10 indexed citations

10.

Filippone, Alessia, Giovanna Casili, Marika Lanza, et al.. (2022). Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness. Cancers. 14(16). 4032–4032. 17 indexed citations

11.

Markovic, Uroš, et al.. (2022). Utility of Procalcitonin and Interleukin-6 As Severe Infection Biomarkers in Adulthematological and Oncological Patients. Real-Life Single Center Prospective Observational Study. Blood. 140(Supplement 1). 12931–12932.

12.

Pavone, Giuliana, Lucia Motta, Federica Martorana, Gianmarco Motta, & Paolo Vigneri. (2021). A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors. Molecules. 26(23). 7294–7294. 23 indexed citations

13.

Vitale, Silvia Rita, Federica Martorana, Stefania Stella, et al.. (2021). PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance. Critical Reviews in Oncology/Hematology. 162. 103334–103334. 30 indexed citations

14.

Martorana, Federica, Gianmarco Motta, Giuliana Pavone, et al.. (2021). AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?. Frontiers in Pharmacology. 12. 662232–662232. 160 indexed citations breakdown →

15.

Martorana, Federica, Giuliana Pavone, Lucia Motta, et al.. (2021). Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases. SHILAP Revista de lepidopterología. 2021. 1–5. 1 indexed citations

16.

Valerio, Maria Rosaria, Mario Mauro, Calogero Cipolla, et al.. (2021). Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer. American Journal of Clinical Oncology. 44(3). 105–108. 3 indexed citations

17.

Manzella, Livia, Michele Massimino, Stefania Stella, et al.. (2019). Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment. International Journal of Molecular Sciences. 20(13). 3258–3258. 41 indexed citations

18.

Tirrò, Elena, Federica Martorana, Chiara Romano, et al.. (2019). Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice. Genes. 10(9). 709–709. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact